ORLANDO, Fla. — The Florida Department of Transportation will give drivers a chance to test the new I-4 Express lanes for free after they open, which is expected by 10 a.m. Saturday. The free access ...

Eric Idle has spoken out about his former co-star John Cleese, following the Monty Python icon's flurry of political posts on X/Twitter. The pair famously starred in the beloved BBC sitcom for five ...

15:49, Tue, Mar 10, 2026 Updated: 15:53, Tue, Mar 10, 2026 Women might be able to learn if they are at risk of dementia "decades before symptoms appear", a new study has discovered. Scientists who ...

Microsoft has added official Python support to Aspire 13, expanding the platform beyond .NET and JavaScript for building and running distributed apps. Documented today in a Microsoft DevBlogs post, ...

Abstract: This study proposes a semi-automated generation method for Web API test cases based on front-end behavior-driven testing, called BATCG (BDD-based API Test Case Generation). BATCG uses the ...

Bank of America Securities analyst Mihir Bhatia noted on Monday that American Express Co. (NYSE:AXP) and Capital One Financial Corp. (NYSE:COF) both passed the Federal Reserve Board’s 2025 Dodd-Frank ...

MinIO, the leader in high-performance object storage for the exabyte AI era, is debuting new AIStor support for Amazon's S3 Express API, becoming the first and only AI data storage platform to adopt ...

Cybersecurity company Snyk Ltd. today announced the launch of Snyk API & Web, a new dynamic application security testing or DAST solution designed to meet the growing demands of modern and ...

Gene expression testing, such as Oncotype DX, aids in chemotherapy decisions for hormone receptor-positive breast cancer, though challenges exist for premenopausal patients with scores under 25.

Castle Biosciences (CSTL) provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis, or AD, who are seeking systemic treatment.

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today provided an update on its test ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...